Skip to main content
BCDA
NASDAQ Life Sciences

BioCardia's CardiAMP CMI Trial Reports 82% Angina Reduction, Durable Exercise Gains

Tom Rudovsky · Reported by GlobeNewswire
More coverage: Biotech Stocks · Healthcare
Sentiment info
Positive
Importance info
9
Price
$0.922
Mkt Cap
$10.465M
52W Low
$0.84
52W High
$2.45
52W Position info
9.7% above low
Off High info
62% below high
Rel. Volume info
0.8× avg
Market data snapshot near publication time

BCDA is trading near its 52-week low of $0.84 (9.7% above the low).

Summary

BioCardia reported strong preliminary results from its CardiAMP Chronic Myocardial Ischemia (CMI) trial at EuroPCR, showing an average 82% reduction in angina episodes and a 179-second increase in exercise tolerance that lasted two years. This positive clinical development is crucial for the company, which is facing severe liquidity issues, a cash runway only until June 2026, and Nasdaq delisting risk, as detailed in recent SEC filings. The robust data for a therapy addressing a significant unmet medical need could be a lifeline, potentially attracting vital funding or partnership interest.

At the time of this announcement, BCDA was trading at $0.92 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $10.5M. The 52-week trading range was $0.84 to $2.45. This news item was assessed with positive market sentiment and an importance score of 9 out of 10. Source: GlobeNewswire.


Price Chart

Share this article

Copied!

BCDA - Latest Insights

BCDA
Nov 20, 2026, 4:31 PM EST
Filing Type: 8-K
Importance Score:
8
Price at Filing: $0.785
Real-time Price: $0.750 info
Change: -$0.035 (-4%) info
Market Cap: $11.884M info
BCDA
Nov 12, 2026, 4:06 PM EST
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $0.831
Real-time Price: $0.750 info
Change: -$0.081 (-10%) info
Market Cap: $11.884M info
BCDA
Oct 07, 2026, 9:00 AM EDT
Source: Wiseek News
Importance Score:
7
Price at Filing: $1.10
Real-time Price: $0.750 info
Change: -$0.3461 (-32%) info
Market Cap: $11.884M info
BCDA
Aug 24, 2026, 8:30 AM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $0.980
Real-time Price: $0.750 info
Change: -$0.230 (-23%) info
Market Cap: $11.884M info
BCDA
Aug 21, 2026, 4:34 PM EDT
Filing Type: 8-K
Importance Score:
9
Price at Filing: $1.01
Real-time Price: $0.750 info
Change: -$0.260 (-26%) info
Market Cap: $11.884M info